• Home
    • Technology
    • Gaming
    • Entertainment
    • World & Business
    • Science
    • Sports
    • AI
    HomeTechnologyGamingEntertainmentWorld & BusinessScienceSportsAI
    Science

    Ivonescimab reportedly improves overall survival over pembrolizumab in advanced lung cancer

    A science and health roundup highlights the reported survival benefit alongside other lung cancer results, including a combination therapy that missed its endpoints.

    WeAD, We ADvertise Community ChannelWW
    1 Source, 31d ago, first seen 31d ago

    TLDR

    A science and health roundup says ivonescimab improved overall survival compared with pembrolizumab in advanced lung cancer. It also highlights other lung cancer trial readouts, noting that one combination therapy missed its endpoints.

    Combined views

    320

    1 Source, first seen 31d ago

    3 likes2 comments1 reposts

    Combined views

    320

    1 Source, first seen 31d ago

    3 likes2 comments1 reposts

    Sentiment

    Positive——Negative

    Summary

    Not enough discussion yet.

    No sentiment analysis available yet.

    Sentiment

    Positive——Negative

    Summary

    Not enough discussion yet.

    No sentiment analysis available yet.

    1 Source

    WeAD, We ADvertise Community Channel@weadvertizers🔬 Morning Brief — 14 Sep 2026 Today's science and health desks bring planetary puzzles, a deep-time water finding, and a busy run of cancer trial results. • Venus's pale yellow clouds may hide something surprisingly dark • Water was fueling volcanoes on Earth 3 billion years ago, scientists find • Magnetic nanoparticles detect amoxicillin allergy with 98% sensitivity in early tests • MRI surveillance may beat preventive brain radiation in small-cell lung cancer • Ivonescimab improves overall survival versus pembrolizumab in advanced lung cancer Watch the lung cancer readouts closely — several trials moved survival, while one combination therapy missed its endpoints. Go to WeAD Platform / Global Trade to stay updated with the news. @soneium @StartaleApp @StartaleGroup @weadvertize (Soundchains Community)31d
    • Home
    • Technology
    • Gaming
    • Entertainment
    • World & Business
    • Science
    • Sports
    • AI
    pembrolizumab

    1 Source

    WeAD, We ADvertise Community Channel@weadvertizers🔬 Morning Brief — 14 Sep 2026 Today's science and health desks bring planetary puzzles, a deep-time water finding, and a busy run of cancer trial results. • Venus's pale yellow clouds may hide something surprisingly dark • Water was fueling volcanoes on Earth 3 billion years ago, scientists find • Magnetic nanoparticles detect amoxicillin allergy with 98% sensitivity in early tests • MRI surveillance may beat preventive brain radiation in small-cell lung cancer • Ivonescimab improves overall survival versus pembrolizumab in advanced lung cancer Watch the lung cancer readouts closely — several trials moved survival, while one combination therapy missed its endpoints. Go to WeAD Platform / Global Trade to stay updated with the news. @soneium @StartaleApp @StartaleGroup @weadvertize (Soundchains Community)31d
    Today's Rank

    —

    Not ranked yet

    Today's Rank

    —

    Not ranked yet